Coforge Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹3,422Cr
- +47.6% YoY
- +5% QoQ
- Net profit
- ₹307Cr
- +34.1% YoY
- +19.9% QoQ
- Margin
- 15%
- −2 pp YoY
- +2 pp QoQ
Guidance rank: #16 of 39 in IT - Software
See the sector's top 10 — free with your mobile number.
The short version
Coforge expects very strong growth in FY2026, driven by a record signed order book 47.7% higher than last year. Coforge expects very strong growth in FY2026, driven by a record signed order book 47.7% higher than the previous year.
From Coforge Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Coforge expects very strong growth in FY2026, driven by a record signed order book 47.7% higher than last year.
- Growth momentum of 30%+ seen in FY2025 is expected to be maintained in FY2026, supported by large deal wins including the Sabre contract.
- The company's pipeline of large deals remains healthy, with consistent year-on-year increase in both number and median size of deals.
- Growth is expected to be balanced across geographies, industry verticals, and service lines.
- The ramp-up of large deals like Sabre will continue over the next few quarters, contributing significantly to volumes.
- Coforge targets reaching $2 billion in revenue by FY2027, aiming to potentially achieve this milestone earlier.
2 more points from Coforge Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Coforge Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company made acquisitions during the year: a data and cloud asset in the US generating $6 million quarterly revenue and a ServiceNow asset in Australia generating $2 million quarterly revenue.
- Revenues from these acquisitions will largely offset the sale of the AdvantageGo business.
- There is a focus on investing in delivery operations and capability build, particularly around AI and GenAI solutions, with over 200 real-world AI solutions developed and deployed.
- Investments are also evident in hiring new leadership (e.g., in Australia) and ramping up headcount to support large deal ramp-ups.
Top-ranked in IT - Software
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Coforge Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Total order intake in Q4 was $2,136 million, marking an exceptional quarter.
- Fiscal year 2025 recorded the highest ever annual order intake of $3.5 billion, up 75.1% year-on-year.
- The executable order book, representing locked orders for the next 12 months, stands at a record $1.5 billion.
2 more points from Coforge Ltd's call on order book
Create a free account to keep reading this call
Coforge Ltd — Quarterly revenue & net profit
Coforge Ltd Q4 FY25 results — key figures
| ₹ Cr | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 3,422 | 2,318 | +47.6% | 3,258 | +5% |
| Operating profit (EBITDA) | 527 | 390 | +35.1% | 435 | +21.1% |
| Operating margin | 15% | 17% | -2 pp | 13% | +2 pp |
| Profit before tax | 395 | 288 | +37.2% | 343 | +15.2% |
| Net profit (PAT) | 307 | 229 | +34.1% | 256 | +19.9% |
| EPS (₹) | 7.81 | 7.24 | +7.9% | 6.45 | +21.1% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹6.2K Cr, net profit ₹605 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Coforge's management said in earlier quarters
Others in IT - Software this season
- ASM Technologies (Q4 FY25)
Q4 FY24: ₹445.92 million . Key concall takeaways from ASM Technologies Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Quick Heal Tech (Q4 FY25)
Q4 FY25 Revenue: ₹65.1 Cr, down from ₹80.0 Cr in Q4 FY24 (approx. Key concall takeaways from Quick Heal Technologies Ltd's Q4 FY25 earnings call — and how it…
- Olatech Solution (Q4 FY25)
Current order book in hand: ₹35 crores (as of June 2025). Key concall takeaways from Olatech Solutions Ltd's Q4 FY25 earnings call — and how it ranks against…
- Birlasoft Ltd (Q4 FY25)
The company has a strong cash position with cash and cash equivalents growing 24% YoY to $259.5 million as of FY25 end. Key concall takeaways from Birlasoft…
Potential multibaggers · Q2 FY27
Potential multibaggers in IT - Software
on management's own guidance
- Strong growth2
- Strong growth1
- Fractal AnalyticsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Coforge Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Coforge Ltd Q4 FY25 results?
Coforge expects very strong growth in FY2026, driven by a record signed order book 47.7% higher than last year. Coforge expects very strong growth in FY2026, driven by a record signed order book 47.7% higher than the previous year.
What is Coforge Ltd share price analysis?
Coforge Ltd currently shows a neutral. The stock trades at a P/E of 41.9 with a market cap of ₹80,257 Cr. Investors should review the full earnings analysis for detailed insights.
Is Coforge Ltd planning capital expenditure?
The company made acquisitions during the year: a data and cloud asset in the US generating $6 million quarterly revenue and a ServiceNow asset in Australia generating $2 million quarterly revenue.
Keep Coforge Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
